Effects of poly (ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats

Thomas Michael Gibson, Mary Anne Cotter, Norman E Cameron

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Diabetes mellitus compromises nitric oxide (NO)-mediated endothelium-dependent relaxation of blood vessels, which has been linked to the excessive generation of reactive oxygen species. There are also deleterious effect on nitrergic innervation, contributing to autonomic neuropathy symptoms such as impotence and gastroporesis. Poly(ADP-ribose) polymerase (PARP) is a nuclear protein stimulated by DNA damage, caused, for example, by oxidative stress. Activation has been linked to impaired endothelial nitric oxide synthase (eNOS)-mediated vasodilation in experimental diabetes. There is no information on the potential role of PARP in nitrergic nerve dysfunction, therefore, the aim was to examine the effects of PARP inhibition, using 3-aminobenzamide (3-AB) on neurally mediated gastric fundus relaxation in streptozotocin-induced diabetic rats. Eight weeks of diabetes caused a 42.5% deficit in maximum relaxation of in vitro gastric fundus strips to electrical stimulation of the non-adrenergic non-cholinergic innervation. This was largely prevented or corrected (4 weeks of treatment following 4 weeks of untreated diabetes) by 3-AB. Diabetes also markedly attenuated the maintenance of relaxation responses to prolonged stimulation, and this was partially corrected by 3-AB treatment. Experiments in the presence of the NOS inhibitor, NG-nitro-l-arginine, and/or blockade of the co-transmitter, vasoactive intestinal polypeptide, by a-chymotrypsin, showed that the beneficial effects of 3-AB were primarily due to improved nitrergic neurotransmission. Thus, PARP plays an important role in defective nitrergic neurotransmission in experimental diabetes, which may have therapeutic implications for treatment of aspects of diabetic autonomic neuropathy.

Original languageEnglish
Pages (from-to)344-350
Number of pages7
JournalNitric Oxide: Biology and Chemistry
Volume15
Issue number4
Early online date27 Apr 2006
DOIs
Publication statusPublished - Dec 2006

Keywords

  • diabetes
  • rat
  • gastric fundus
  • nitric oxide
  • nitrergic neurotransmission
  • poly(ADP-ribose) polymerase
  • PARP
  • smooth muscle
  • 3-aminobenzamide
  • alpha-lipoic acid
  • glycation end-products
  • nitric-oxide
  • oxidative stress
  • nitrergic neuropathy
  • corpus cavernosum
  • energy-metabolism
  • in-vivo
  • antioxidant
  • aminoguanidine

Cite this

Effects of poly (ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats. / Gibson, Thomas Michael; Cotter, Mary Anne; Cameron, Norman E.

In: Nitric Oxide: Biology and Chemistry, Vol. 15, No. 4, 12.2006, p. 344-350.

Research output: Contribution to journalArticle

@article{b82664b840e04ed486e26de0e317b7d3,
title = "Effects of poly (ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats",
abstract = "Diabetes mellitus compromises nitric oxide (NO)-mediated endothelium-dependent relaxation of blood vessels, which has been linked to the excessive generation of reactive oxygen species. There are also deleterious effect on nitrergic innervation, contributing to autonomic neuropathy symptoms such as impotence and gastroporesis. Poly(ADP-ribose) polymerase (PARP) is a nuclear protein stimulated by DNA damage, caused, for example, by oxidative stress. Activation has been linked to impaired endothelial nitric oxide synthase (eNOS)-mediated vasodilation in experimental diabetes. There is no information on the potential role of PARP in nitrergic nerve dysfunction, therefore, the aim was to examine the effects of PARP inhibition, using 3-aminobenzamide (3-AB) on neurally mediated gastric fundus relaxation in streptozotocin-induced diabetic rats. Eight weeks of diabetes caused a 42.5{\%} deficit in maximum relaxation of in vitro gastric fundus strips to electrical stimulation of the non-adrenergic non-cholinergic innervation. This was largely prevented or corrected (4 weeks of treatment following 4 weeks of untreated diabetes) by 3-AB. Diabetes also markedly attenuated the maintenance of relaxation responses to prolonged stimulation, and this was partially corrected by 3-AB treatment. Experiments in the presence of the NOS inhibitor, NG-nitro-l-arginine, and/or blockade of the co-transmitter, vasoactive intestinal polypeptide, by a-chymotrypsin, showed that the beneficial effects of 3-AB were primarily due to improved nitrergic neurotransmission. Thus, PARP plays an important role in defective nitrergic neurotransmission in experimental diabetes, which may have therapeutic implications for treatment of aspects of diabetic autonomic neuropathy.",
keywords = "diabetes, rat, gastric fundus, nitric oxide, nitrergic neurotransmission, poly(ADP-ribose) polymerase, PARP, smooth muscle, 3-aminobenzamide, alpha-lipoic acid, glycation end-products, nitric-oxide, oxidative stress, nitrergic neuropathy, corpus cavernosum, energy-metabolism, in-vivo, antioxidant, aminoguanidine",
author = "Gibson, {Thomas Michael} and Cotter, {Mary Anne} and Cameron, {Norman E}",
year = "2006",
month = "12",
doi = "10.1016/j.niox.2006.03.003",
language = "English",
volume = "15",
pages = "344--350",
journal = "Nitric Oxide: Biology and Chemistry",
issn = "1089-8603",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of poly (ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats

AU - Gibson, Thomas Michael

AU - Cotter, Mary Anne

AU - Cameron, Norman E

PY - 2006/12

Y1 - 2006/12

N2 - Diabetes mellitus compromises nitric oxide (NO)-mediated endothelium-dependent relaxation of blood vessels, which has been linked to the excessive generation of reactive oxygen species. There are also deleterious effect on nitrergic innervation, contributing to autonomic neuropathy symptoms such as impotence and gastroporesis. Poly(ADP-ribose) polymerase (PARP) is a nuclear protein stimulated by DNA damage, caused, for example, by oxidative stress. Activation has been linked to impaired endothelial nitric oxide synthase (eNOS)-mediated vasodilation in experimental diabetes. There is no information on the potential role of PARP in nitrergic nerve dysfunction, therefore, the aim was to examine the effects of PARP inhibition, using 3-aminobenzamide (3-AB) on neurally mediated gastric fundus relaxation in streptozotocin-induced diabetic rats. Eight weeks of diabetes caused a 42.5% deficit in maximum relaxation of in vitro gastric fundus strips to electrical stimulation of the non-adrenergic non-cholinergic innervation. This was largely prevented or corrected (4 weeks of treatment following 4 weeks of untreated diabetes) by 3-AB. Diabetes also markedly attenuated the maintenance of relaxation responses to prolonged stimulation, and this was partially corrected by 3-AB treatment. Experiments in the presence of the NOS inhibitor, NG-nitro-l-arginine, and/or blockade of the co-transmitter, vasoactive intestinal polypeptide, by a-chymotrypsin, showed that the beneficial effects of 3-AB were primarily due to improved nitrergic neurotransmission. Thus, PARP plays an important role in defective nitrergic neurotransmission in experimental diabetes, which may have therapeutic implications for treatment of aspects of diabetic autonomic neuropathy.

AB - Diabetes mellitus compromises nitric oxide (NO)-mediated endothelium-dependent relaxation of blood vessels, which has been linked to the excessive generation of reactive oxygen species. There are also deleterious effect on nitrergic innervation, contributing to autonomic neuropathy symptoms such as impotence and gastroporesis. Poly(ADP-ribose) polymerase (PARP) is a nuclear protein stimulated by DNA damage, caused, for example, by oxidative stress. Activation has been linked to impaired endothelial nitric oxide synthase (eNOS)-mediated vasodilation in experimental diabetes. There is no information on the potential role of PARP in nitrergic nerve dysfunction, therefore, the aim was to examine the effects of PARP inhibition, using 3-aminobenzamide (3-AB) on neurally mediated gastric fundus relaxation in streptozotocin-induced diabetic rats. Eight weeks of diabetes caused a 42.5% deficit in maximum relaxation of in vitro gastric fundus strips to electrical stimulation of the non-adrenergic non-cholinergic innervation. This was largely prevented or corrected (4 weeks of treatment following 4 weeks of untreated diabetes) by 3-AB. Diabetes also markedly attenuated the maintenance of relaxation responses to prolonged stimulation, and this was partially corrected by 3-AB treatment. Experiments in the presence of the NOS inhibitor, NG-nitro-l-arginine, and/or blockade of the co-transmitter, vasoactive intestinal polypeptide, by a-chymotrypsin, showed that the beneficial effects of 3-AB were primarily due to improved nitrergic neurotransmission. Thus, PARP plays an important role in defective nitrergic neurotransmission in experimental diabetes, which may have therapeutic implications for treatment of aspects of diabetic autonomic neuropathy.

KW - diabetes

KW - rat

KW - gastric fundus

KW - nitric oxide

KW - nitrergic neurotransmission

KW - poly(ADP-ribose) polymerase

KW - PARP

KW - smooth muscle

KW - 3-aminobenzamide

KW - alpha-lipoic acid

KW - glycation end-products

KW - nitric-oxide

KW - oxidative stress

KW - nitrergic neuropathy

KW - corpus cavernosum

KW - energy-metabolism

KW - in-vivo

KW - antioxidant

KW - aminoguanidine

U2 - 10.1016/j.niox.2006.03.003

DO - 10.1016/j.niox.2006.03.003

M3 - Article

VL - 15

SP - 344

EP - 350

JO - Nitric Oxide: Biology and Chemistry

JF - Nitric Oxide: Biology and Chemistry

SN - 1089-8603

IS - 4

ER -